Suppr超能文献

相似文献

1
CTLA-4 trafficking and surface expression.
Trends Immunol. 2008 Jun;29(6):272-9. doi: 10.1016/j.it.2008.02.011. Epub 2008 May 9.
2
CD28 and CTLA-4 coreceptor expression and signal transduction.
Immunol Rev. 2009 May;229(1):12-26. doi: 10.1111/j.1600-065X.2009.00770.x.
3
T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor.
Immunity. 2006 Nov;25(5):807-21. doi: 10.1016/j.immuni.2006.08.024. Epub 2006 Oct 26.
4
TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.
J Immunol. 2006 Nov 15;177(10):6833-41. doi: 10.4049/jimmunol.177.10.6833.
5
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
Immunol Rev. 2008 Aug;224:166-82. doi: 10.1111/j.1600-065X.2008.00662.x.
6
CTLA-4 co-receptor impacts on the function of Treg and CD8+ T-cell subsets.
Eur J Immunol. 2009 Mar;39(3):687-90. doi: 10.1002/eji.200939261.
7
T-cell regulation by CD28 and CTLA-4.
Nat Rev Immunol. 2001 Dec;1(3):220-8. doi: 10.1038/35105024.
9
Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1524-8. doi: 10.1073/pnas.0910341107. Epub 2010 Jan 4.
10
Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation.
J Biol Chem. 2019 Apr 12;294(15):6017-6026. doi: 10.1074/jbc.RA119.007455. Epub 2019 Feb 13.

引用本文的文献

1
Negative Immune Checkpoint Inhibitors.
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
3
Role of lysine-specific demethylase 1 in immunotherapy of gastric cancer: An update.
Chin J Cancer Res. 2024 Dec 30;36(6):669-682. doi: 10.21147/j.issn.1000-9604.2024.06.06.
6
Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy.
Cancers (Basel). 2024 May 24;16(11):1995. doi: 10.3390/cancers16111995.
7
CRP and soluble CTLA4 are determinants of anti-PD1 resistance in gastrointestinal cancer.
Am J Cancer Res. 2024 Mar 15;14(3):1174-1189. doi: 10.62347/NQBL9998. eCollection 2024.
8
Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic Colorectal Cancer.
Medicina (Kaunas). 2024 Feb 26;60(3):397. doi: 10.3390/medicina60030397.
9
Modern cancer therapy: cryoablation meets immune checkpoint blockade.
Front Oncol. 2024 Feb 7;14:1323070. doi: 10.3389/fonc.2024.1323070. eCollection 2024.
10
Five Inhibitory Receptors Display Distinct Vesicular Distributions in Murine T Cells.
Cells. 2023 Oct 31;12(21):2558. doi: 10.3390/cells12212558.

本文引用的文献

3
Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter.
J Immunol. 2007 Sep 15;179(6):3831-40. doi: 10.4049/jimmunol.179.6.3831.
4
TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression.
J Immunol. 2006 Nov 15;177(10):6833-41. doi: 10.4049/jimmunol.177.10.6833.
5
T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor.
Immunity. 2006 Nov;25(5):807-21. doi: 10.1016/j.immuni.2006.08.024. Epub 2006 Oct 26.
6
Retrograde transport from endosomes to the trans-Golgi network.
Nat Rev Mol Cell Biol. 2006 Aug;7(8):568-79. doi: 10.1038/nrm1985.
7
Reversal of the TCR stop signal by CTLA-4.
Science. 2006 Sep 29;313(5795):1972-5. doi: 10.1126/science.1131078. Epub 2006 Aug 24.
8
ARF proteins: roles in membrane traffic and beyond.
Nat Rev Mol Cell Biol. 2006 May;7(5):347-58. doi: 10.1038/nrm1910.
9
Normal T-cell development and immune functions in TRIM-deficient mice.
Mol Cell Biol. 2006 May;26(9):3639-48. doi: 10.1128/MCB.26.9.3639-3648.2006.
10
A molecular perspective of CTLA-4 function.
Annu Rev Immunol. 2006;24:65-97. doi: 10.1146/annurev.immunol.24.021605.090535.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验